The 1.4 million-ft² facility employs 2,500 people and is the largest manufacturer of intravenous and peritoneal dialysis ...

Most of Nashville's hospitals have a healthy supply of fluids, but they are continuing to assess sometimes daily and search ...

CFO Joel Grade told investors Friday that Baxter expects an approximately $200 million hit to sales in the fourth quarter ...

On Oct. 9, the U.S. Food & Drug Administration authorized Baxter to import intravenous solution and dialysis products from sites in Canada, China, Ireland and the U.K. Airlifting in supplies is ...

Baxter expects to reach 100% allocation across several IV product codes by the end of 2023. The company plans to increase production capacity through phased updates in late November, mid-December and ...

Baxter International (BAX) stock slips as the company with its Q3 2024 results lowers guidance to reflect a $200M revenue hit ...

The medical supply manufacturer said initial batches will not be ready to ship until late November at the earliest.

The company, which is a key producer for American healthcare providers, was hit by the hurricane when it tore through western ...

Baxter expects to restart a second IV solutions manufacturing line within the next week, the company announced Nov. 7. Along ...

will begin accepting more new home dialysis patients after hurricane ... The first shipments arrived over the weekend, Baxter ...

Baxter International cut its annual profit forecast on Friday due to a hurricane-related hit to its intravenous solutions facility, sending its shares down 3.3% in premarket trading.